In the patients with cholesteatoma, serum MPO activity and levels of MDA, 4-HNE, and NO were significantly higher, and TAC levels were significantly lower than in the patients without cholesteatoma, though the differences between the groups were not statistically significant. The gene discussed is MPO; the disease is cholesteatoma.